Investors

Growing Shareholder Value

Press Releases

FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients

Aug 04, 2020
Read More
Additional Formats
PDF Version

Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump

Jul 30, 2020
Read More
Additional Formats
PDF Version

Abiomed First Quarter Fiscal 2021 Earnings and Conference Call Notification

Jul 16, 2020
Read More
Additional Formats
PDF Version

FDA Approves Data Streaming from the Impella Console, Setting the Stage for Artificial Intelligence Algorithms to Further Improve Patient Outcomes

Jul 16, 2020
Read More
Additional Formats
PDF Version

Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist

Jul 01, 2020
Read More
Additional Formats
PDF Version

Abiomed Launches Virtual Physician Education Program, CAMP PCI, to Improve High-Risk PCI Patient Outcomes

Jun 16, 2020
Read More
Additional Formats
PDF Version

Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D.

Jun 15, 2020
Read More
Additional Formats
PDF Version

FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump

Jun 05, 2020
Read More
Additional Formats
PDF Version

Abiomed to Hold Fireside Chat at the William Blair 40th Annual Growth Stock Conference

Jun 03, 2020
Read More
Additional Formats
PDF Version

FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure

Jun 01, 2020
Read More
Additional Formats
PDF Version
View all